Palo Alto-based cancer test developer Guardant Health cuts 130 jobs For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | January 26, 2023 The move comes about a month after the company’s stock dropped by about 30% when it reported trial results of a test for colorectal cancer that disappointed some of its investors. Posted in Sacramento Business Journal